Hostname: page-component-74656f9884-kv2lp Total loading time: 0 Render date: 2026-11-06T10:08:10.260Z Has data issue: false hasContentIssue false

Structural modelling studies and immunoprophylactic potential of Brugia malayi DEAD Box RNA helicase

Published online by Cambridge University Press:  07 June 2013

MEGHNA SINGH
Affiliation:
Division of Parasitology, CSIR-Central Drug Research Institute, BS10/1, Sector 10, Jankipuram extension, Sitapur Road, Lucknow 226021, Uttar Pradesh, India
NIDHI SHRIVASTAVA
Affiliation:
Division of Parasitology, CSIR-Central Drug Research Institute, BS10/1, Sector 10, Jankipuram extension, Sitapur Road, Lucknow 226021, Uttar Pradesh, India
UZMA SAQIB
Affiliation:
Molecular and Structural Biology Division, CSIR-Central Drug Research Institute, BS10/1, Sector 10, Jankipuram extension, Sitapur Road, Lucknow 226021, Uttar Pradesh, India
MOHAMMAD IMRAN SIDDIQI
Affiliation:
Molecular and Structural Biology Division, CSIR-Central Drug Research Institute, BS10/1, Sector 10, Jankipuram extension, Sitapur Road, Lucknow 226021, Uttar Pradesh, India
SHAILJA MISRA-BHATTACHARYA*
Affiliation:
Division of Parasitology, CSIR-Central Drug Research Institute, BS10/1, Sector 10, Jankipuram extension, Sitapur Road, Lucknow 226021, Uttar Pradesh, India
*
*Corresponding author: Division of Parasitology, Central Drug Research Institute, Lucknow-226021, UP, India. Tel: +91 522 2612411 18. PABX 4221/4224. Fax: +91 522 2623405/2623938/2629504. E-mail: shailja_cdri@rediffmail.com, shailjacdri@yahoo.com
Rights & Permissions [Opens in a new window]

Summary

DEAD Box RNA helicases are essential enzymes that are involved in RNA metabolic processes such as transcription, pre-mRNA splicing, translation initiation and RNA decay. We have previously over-expressed and biochemically characterized an immunodominant cDNA clone encoding DEAD box RNA helicase (BmL3-Helicase) isolated by immunoscreening of the larval stage cDNA library of Brugia malayi. In the current study, the 3D structure was determined and the immunoprophylactic efficacy of BmL3-Helicase was investigated by immunizing Mastomys coucha with the recombinant protein and subsequently challenging with B. malayi infective larvae. The immunization had an adverse outcome on the establishment of challenged larvae resulting in a 67·4% reduction in adult parasite recovery, a 86·7% decrease in the microfilarial density and profound sterility of the recovered female worms. The immune response thus generated was investigated by measuring the levels of specific antibodies including IgG subclasses, reactive oxygen species and cytokines.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2013 
Figure 0

Fig. 1. Three-dimensional homology model of Brugia malayi RNA Helicase using Modeler and PROCHECK. (A) Homology model structure of BmL3-Helicase showing conserved DEAD domain. (B) Superposition of BmL3-Helicase (model, light grey shade) with the Homo sapiens RNA helicase crystal structure (template, dark grey shade). The DEAD box domain of BmL3-Helicase (light grey shade) and template (dark grey shade) is depicted by the ball and stick model.

Figure 1

Table 1. Summarized table for adult worm recovery, reduction in worm burden and female worm sterilization in immunized and control groups

Figure 2

Fig. 2. Microfilarial kinetics in Mastomys coucha immunized with BmL3-Helicase, adjuvant or PBS. Blood microfilaraemia was determined after 12–28 weeks post challenge. In all the experimental groups microfilarial density was low during the initial monitoring period and increased subsequently in the following weeks, but remained low in the BmL3-Helicase immunized group throughout the observation period. Each point represents the mean±s.e.

Figure 3

Fig. 3. Humoral antibody response in various experimental groups. (A) Kinetics of BmL3-Helicase specific IgG antibody response in the sera of mastomys. All animals were free of BmL3-Helicase specific antibodies on the day of initiation of vaccination (1). The recombinant protein generated a gradually increasing IgG antibody level following each immunizing dose, reaching a maximum on day 7 post-final protein booster (2) and did not increase further post-L3 challenge (3, 4) but remained high even up to the day of autopsy (5) in the BmL3-Helicase immunized group. The PBS and adjuvant groups did not develop a BmL3-Helicase specific IgG response. (B) BmL3-Helicase specific IgG isotypes levels in sera of mastomys of different groups. The IgG1, IgG2a, IgG2b, IgG3 and IgA antibodies were checked by use of ELISA for specific antibodies against BmL3-Helicase. The BmL3-Helicase immunized group (dark shaded bar), showed a significant increase in IgG1 (P < 0·05), IgG3 isotypes and IgA (P < 0·01) antibody as compared with the PBS control (open bars), adjuvant control group (light shaded bar). OD values (at 492 nm) are shown as the mean±s.e.

Figure 4

Fig. 4. Antibody dependent cellular adhesion to the surface of (A) microfilariae, (B) infective larvae. Photographs were captured on a phase-contrast fluorescent microscope (Nikon, Japan) at 40 ×  magnification. Arrows indicate adhered cells. Scale bar=100 μm.

Figure 5

Fig. 5. Immunophenotyping of CD4+, CD8+ cell surface marker. (A) The flow-cytometric analysis of CD4+ T cells in BmL3-Helicase immunized group (open circular dots), PBS (closed circular dots) or adjuvant control group (triangular dots). (B) The flow-cytometric analysis of CD8+ T cells in BmL3-Helicase immunized group (open circular dots), PBS (closed circular dots) or adjuvant control group (triangular dots). Data are represented as scatter plots where each dot represents the value for an individual animal. The lines drawn parallel to the X-axis represent the mean values. P < 0·01 was considered as highly significant.

Figure 6

Fig. 6. Immunophenotyping of CD45+, CD80+ cell surface marker. (A) The flow-cytometric analysis of CD45+ markers in the BmL3-Helicase immunized group (open circular dots), PBS (closed circular dots) or adjuvant control group (triangular dots). (B) The flow-cytometric analysis of CD80+ marker in the BmL3-Helicase immunized group (open circular dots), PBS (closed circular dots) or adjuvant control group (triangular dots). Data are represented as scatter plots where each dot represents the value for an individual animal. The lines drawn parallel to the X-axis represent the mean values. P < 0·01 was considered as highly significant.

Figure 7

Fig. 7. Immunophenotyping of CD19 and CD16-32 cell surface marker. (A) The flow-cytometric analysis of CD19 cell surface marker in BmL3-Helicase immunized group (open circular dots), PBS (closed circular dots) or adjuvant control group (triangular dots). (B) The flow-cytometric analysis of CD16-32 cell surface marker in BmL3-Helicase immunized group (open circular dots), PBS (closed circular dots) or adjuvant control group (triangular dots). Data are represented as scatter plots where each dot represents the value for an individual animal. The lines drawn parallel to the X-axis represent the mean value. P < 0·01 was considered as highly significant.

Figure 8

Fig. 8. Measurement of pro-inflammatory and anti-inflammatory cytokines. The flow-cytometric analysis of (A) IL-4, (B) IL-2, (C) IFN-γ and (D) IL-10 cytokines in BmL3-Helicase immunized group (open circular dots), PBS (closed circular dots) or adjuvant control group (triangular dots). Data are represented as scatter plots where each dot represents the value for an individual animal. The lines drawn parallel to the X-axis represent the mean value. P < 0·01 was considered as highly significant.

Figure 9

Fig. 9. Nitric oxide and reactive oxygen species determination by macrophages of immunized and control groups. (A) NO production in the BmL3-Helicase immunized group (dark shaded bar), PBS control (open bar), and adjuvant control (light shaded bar). (B) ROS levels in the BmL3-Helicase immunized group (black bar), PBS control (open bar), and adjuvant control (light shaded bar). Each bar represents the mean±s.e.P < 0·01 was considered as highly significant.